ResMed Inc

$250.84
(as of Jun 18, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Ticker Information for ResMed Inc

Stock Price
$250.84
Ticker Symbol
RMD
Exchange
NYSE

Industry Information for ResMed Inc

Sector
Healthcare
Industry
Medical Instruments & Supplies

Company Description for ResMed Inc

Country
USA
Full Time Employees
0

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Fundamentals for ResMed Inc

Market Capitalization
$34,859,106,304
EBITDA
$1,764,669,952
Dividends per Share
$2.07
P/E Ratio
26.65
Forward P/E Ratio
22.73
Earnings per Share
$8.92
Earnings per Share Estimate Next Year
Profit Margin
26.15%
Shares Outstanding
146,627,008
Percent Owned by Insiders
0.67%
Percent Owned by Institutions
63.02%
52-Week High
52-Week Low

Technical Indicators for ResMed Inc

50-Day Moving Average
200-Day Moving Average
RSI
58.4
4.28

Analyst Ratings for ResMed Inc

Strong Buy
8
Buy
4
Hold
6
Sell
0
Strong Sell
1

News About ResMed Inc

Jun 19, 2025, 12:33 AM EST
A company that generates cash isn’t automatically a winner. See more.
Jun 18, 2025, 8:27 AM EST
ResMed’s first quarter results were met with a strong market response, reflecting in-line revenue and profit performance alongside notable margin expansion. See more.
Jun 17, 2025, 11:33 PM EST
Looking back on patient monitoring stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including DexCom (NASDAQ:DXCM) and its peers. See more.
Jun 13, 2025, 9:35 AM EST
[Health Care Medical Stock Market Industry Sector Wall Street Buildings 3d Illustration] See more.